An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo

Craig Cherrin, Kathleen Haskell, Bonnie Howell, Raymond Jones, Karen Leander, Ronald Robinson, Aubrey Watkins, Mark Bilodeau, Jacob Hoffman, Philip Sanderson, George Hartman, Elizabeth Mahan, Thomayant Prueksaritanont, Guoqiang Jiang, Qing Bai She, Neal Rosen, Laura Sepp-Lorenzino, Deborah Defeo-Jones, Hans E. Huber

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science